Cargando…
Malignant peritoneal mesothelioma. Is there a new treatment?
The authors report a novel, alternative approach to treat malignant peritoneal mesothelioma (MPeM) targeting, vascular endothelial growth factor (VEGF) using anti-VEGF (bevacizumab) chemotherapy combination.
Autores principales: | Rasul, Kakil Ibrahim, Kerr, David J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994480/ https://www.ncbi.nlm.nih.gov/pubmed/21139928 http://dx.doi.org/10.4081/rt.2009.e49 |
Ejemplares similares
-
Peritoneal Malignant Psammomatous Mesothelioma
por: Pusiol, Teresa, et al.
Publicado: (2010) -
Malignant Peritoneal Mesothelioma: A Rare Cause of Ascites
por: Ibrahim, Abdisamad M., et al.
Publicado: (2018) -
Malignant peritoneal mesothelioma—a diagnostic challenge
por: Abdul Razzak, Saad, et al.
Publicado: (2022) -
Malignant Peritoneal Mesothelioma Presenting as Mucinous Ascites
por: Field, Zachary, et al.
Publicado: (2018) -
Malignant Peritoneal Mesothelioma Without Asbestos Exposure
por: Abbas, Hafsa, et al.
Publicado: (2019)